360 related articles for article (PubMed ID: 34054832)
1. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
Front Immunol; 2021; 12():664209. PubMed ID: 34054832
[TBL] [Abstract][Full Text] [Related]
2. Quantitative SARS-CoV-2 RT-PCR and Bronchoalveolar Cytokine Concentrations Redefine the COVID-19 Phenotypes in Critically Ill Patients.
Vazquez Guillamet MC; Vazquez Guillamet R; Rjob A; Reynolds D; Parikh B; Despotovic V; Byers DE; Ellebedy AH; Kollef MH; Mudd PA
J Intensive Care Med; 2024 Jun; 39(6):525-533. PubMed ID: 38629466
[TBL] [Abstract][Full Text] [Related]
3. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
[TBL] [Abstract][Full Text] [Related]
4. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B
Front Immunol; 2021; 12():627579. PubMed ID: 33692801
[TBL] [Abstract][Full Text] [Related]
5. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
Front Immunol; 2021; 12():738093. PubMed ID: 34777349
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.
Grasselli G; Tonetti T; Protti A; Langer T; Girardis M; Bellani G; Laffey J; Carrafiello G; Carsana L; Rizzuto C; Zanella A; Scaravilli V; Pizzilli G; Grieco DL; Di Meglio L; de Pascale G; Lanza E; Monteduro F; Zompatori M; Filippini C; Locatelli F; Cecconi M; Fumagalli R; Nava S; Vincent JL; Antonelli M; Slutsky AS; Pesenti A; Ranieri VM;
Lancet Respir Med; 2020 Dec; 8(12):1201-1208. PubMed ID: 32861276
[TBL] [Abstract][Full Text] [Related]
7. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications.
Combadière B; Adam L; Guillou N; Quentric P; Rosenbaum P; Dorgham K; Bonduelle O; Parizot C; Sauce D; Mayaux J; Luyt CE; Boissonnas A; Amoura Z; Pourcher V; Miyara M; Gorochov G; Guihot A; Combadière C
Front Immunol; 2021; 12():752612. PubMed ID: 34616409
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
[TBL] [Abstract][Full Text] [Related]
9. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
[No Abstract] [Full Text] [Related]
10. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
Front Immunol; 2021; 12():716361. PubMed ID: 34491250
[TBL] [Abstract][Full Text] [Related]
11. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
[No Abstract] [Full Text] [Related]
12. Inflammasome-regulated cytokines are critical mediators of acute lung injury.
Dolinay T; Kim YS; Howrylak J; Hunninghake GM; An CH; Fredenburgh L; Massaro AF; Rogers A; Gazourian L; Nakahira K; Haspel JA; Landazury R; Eppanapally S; Christie JD; Meyer NJ; Ware LB; Christiani DC; Ryter SW; Baron RM; Choi AM
Am J Respir Crit Care Med; 2012 Jun; 185(11):1225-34. PubMed ID: 22461369
[TBL] [Abstract][Full Text] [Related]
13. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.
Günther A; Mosavi P; Heinemann S; Ruppert C; Muth H; Markart P; Grimminger F; Walmrath D; Temmesfeld-Wollbrück B; Seeger W
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):454-62. PubMed ID: 10673185
[TBL] [Abstract][Full Text] [Related]
14. Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality.
de Brabander J; Boers LS; Kullberg RFJ; Zhang S; Nossent EJ; Heunks LMA; Vlaar APJ; Bonta PI; Schultz MJ; van der Poll T; Duitman J; Bos LDJ; ; ; ;
Thorax; 2023 Sep; 78(9):912-921. PubMed ID: 37142421
[TBL] [Abstract][Full Text] [Related]
15. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
17. Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
Tabatabai A; Rabin J; Menaker J; Madathil R; Galvagno S; Menne A; Chow JH; Grazioli A; Herr D; Tanaka K; Scalea T; Mazzeffi M
A A Pract; 2020 May; 14(7):e01236. PubMed ID: 32539272
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
19. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
Blot M; Jacquier M; Aho Glele LS; Beltramo G; Nguyen M; Bonniaud P; Prin S; Andreu P; Bouhemad B; Bour JB; Binquet C; Piroth L; Pais de Barros JP; Masson D; Quenot JP; Charles PE;
Crit Care; 2020 Nov; 24(1):632. PubMed ID: 33138839
[TBL] [Abstract][Full Text] [Related]
20. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
de Nooijer AH; Grondman I; Janssen NAF; Netea MG; Willems L; van de Veerdonk FL; Giamarellos-Bourboulis EJ; Toonen EJM; Joosten LAB;
J Infect Dis; 2021 Feb; 223(2):214-224. PubMed ID: 33038254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
